Education/CredentialsDO: Arizona College of Osteopathic MedicineBS: Brigham Young University (Neuroscience) Board Certifications & LicensesAmerican Board of Internal Medicine (Certification Date: 2020-08-20)American Board of Internal Medicine (Endocrinology-Diabetes and Metabolism) (Certification Date: 2023-10-24) LanguagesSpanish SpecialtiesEndocrinology-Diabetes and MetabolismInternal Medicine Contact Information Medical Sciences Building Office 513-558-4444 Email welchaw@ucmail.uc.edu Clinical Interests DiabetesDiabetes MellitusDiabetes Type 1 (Diabetes Mellitus, Type 1)Diabetes Type 2 (Diabetes Mellitus, Type 2)Diabetic FootDiabetic HypoglycemiaDiabetic KetoacidosisDiabetic NephropathyDiabetic NeuropathiesThyroid CancerAdrenal InsufficiencyAdrenocortical AdenomaCushing syndrome (Hypercortisolism)HyperparathyroidismHyperthyroidismHypothyroidism (Underactive thyroid)ObesityOsteoporosisPituitary AdenomaProlactinoma Peer Reviewed Publications Farahani, Rahele A; Egan, Aoife M; Welch, Andrew A; Laurenti, Marcello C; Cobelli, Claudio; Dalla Man, Chiara; Vella, Adrian 2023. The Effect of Glucagon-Like Peptide 1 Receptor Blockade on Glucagon-Induced Stimulation of Insulin Secretion. Diabetes, 72 4, 449-454Schembri Wismayer, Daniel; Laurenti, Marcello C; Song, Yilin; Egan, Aoife M; Welch, Andrew A; Bailey, Kent R; Cobelli, Claudio; Dalla Man, Chiara; Jensen, Michael D; Vella, Adrian 2023. Effects of acute changes in fasting glucose and free fatty acid concentrations on indices of β-cell function and glucose metabolism in subjects without diabetes. American journal of physiology. Endocrinology and metabolism, 325 2, E119-E131Welch, Andrew A; Farahani, Rahele A; Egan, Aoife M; Laurenti, Marcello C; Zeini, Maya; Vella, Max; Bailey, Kent R; Cobelli, Claudio; Dalla Man, Chiara Dalla; Matveyenko, Aleksey; Vella, Adrian 2023. The effect of Glucagon-Like Peptide-1 Receptor blockade on islet secretion and glucose metabolism in humans. The Journal of clinical investigation, , Brar, Gurkirat S; Barrow, Breanne M; Watson, Matthew; Griesbach, Ryan; Choung, Edwina; Welch, Andrew; Ruzsicska, Bela; Raleigh, Daniel P; Zraika, Sakeneh 2017. Neprilysin Is Required for Angiotensin-(1-7)'s Ability to Enhance Insulin Secretion via Its Proteolytic Activity to Generate Angiotensin-(1-2). Diabetes, 66 8, 2201-2212
Clinical Interests DiabetesDiabetes MellitusDiabetes Type 1 (Diabetes Mellitus, Type 1)Diabetes Type 2 (Diabetes Mellitus, Type 2)Diabetic FootDiabetic HypoglycemiaDiabetic KetoacidosisDiabetic NephropathyDiabetic NeuropathiesThyroid CancerAdrenal InsufficiencyAdrenocortical AdenomaCushing syndrome (Hypercortisolism)HyperparathyroidismHyperthyroidismHypothyroidism (Underactive thyroid)ObesityOsteoporosisPituitary AdenomaProlactinoma
Peer Reviewed Publications Farahani, Rahele A; Egan, Aoife M; Welch, Andrew A; Laurenti, Marcello C; Cobelli, Claudio; Dalla Man, Chiara; Vella, Adrian 2023. The Effect of Glucagon-Like Peptide 1 Receptor Blockade on Glucagon-Induced Stimulation of Insulin Secretion. Diabetes, 72 4, 449-454Schembri Wismayer, Daniel; Laurenti, Marcello C; Song, Yilin; Egan, Aoife M; Welch, Andrew A; Bailey, Kent R; Cobelli, Claudio; Dalla Man, Chiara; Jensen, Michael D; Vella, Adrian 2023. Effects of acute changes in fasting glucose and free fatty acid concentrations on indices of β-cell function and glucose metabolism in subjects without diabetes. American journal of physiology. Endocrinology and metabolism, 325 2, E119-E131Welch, Andrew A; Farahani, Rahele A; Egan, Aoife M; Laurenti, Marcello C; Zeini, Maya; Vella, Max; Bailey, Kent R; Cobelli, Claudio; Dalla Man, Chiara Dalla; Matveyenko, Aleksey; Vella, Adrian 2023. The effect of Glucagon-Like Peptide-1 Receptor blockade on islet secretion and glucose metabolism in humans. The Journal of clinical investigation, , Brar, Gurkirat S; Barrow, Breanne M; Watson, Matthew; Griesbach, Ryan; Choung, Edwina; Welch, Andrew; Ruzsicska, Bela; Raleigh, Daniel P; Zraika, Sakeneh 2017. Neprilysin Is Required for Angiotensin-(1-7)'s Ability to Enhance Insulin Secretion via Its Proteolytic Activity to Generate Angiotensin-(1-2). Diabetes, 66 8, 2201-2212
Farahani, Rahele A; Egan, Aoife M; Welch, Andrew A; Laurenti, Marcello C; Cobelli, Claudio; Dalla Man, Chiara; Vella, Adrian 2023. The Effect of Glucagon-Like Peptide 1 Receptor Blockade on Glucagon-Induced Stimulation of Insulin Secretion. Diabetes, 72 4, 449-454Schembri Wismayer, Daniel; Laurenti, Marcello C; Song, Yilin; Egan, Aoife M; Welch, Andrew A; Bailey, Kent R; Cobelli, Claudio; Dalla Man, Chiara; Jensen, Michael D; Vella, Adrian 2023. Effects of acute changes in fasting glucose and free fatty acid concentrations on indices of β-cell function and glucose metabolism in subjects without diabetes. American journal of physiology. Endocrinology and metabolism, 325 2, E119-E131Welch, Andrew A; Farahani, Rahele A; Egan, Aoife M; Laurenti, Marcello C; Zeini, Maya; Vella, Max; Bailey, Kent R; Cobelli, Claudio; Dalla Man, Chiara Dalla; Matveyenko, Aleksey; Vella, Adrian 2023. The effect of Glucagon-Like Peptide-1 Receptor blockade on islet secretion and glucose metabolism in humans. The Journal of clinical investigation, , Brar, Gurkirat S; Barrow, Breanne M; Watson, Matthew; Griesbach, Ryan; Choung, Edwina; Welch, Andrew; Ruzsicska, Bela; Raleigh, Daniel P; Zraika, Sakeneh 2017. Neprilysin Is Required for Angiotensin-(1-7)'s Ability to Enhance Insulin Secretion via Its Proteolytic Activity to Generate Angiotensin-(1-2). Diabetes, 66 8, 2201-2212